Login to Your Account

Avila, Sanofi-Aventis Shake Hands on $800M Alliance

By Catherine Shaffer

Tuesday, December 21, 2010
Dazzled by science, Sanofi-Aventis SA, of Paris, plunked down $40 million in up-front cash and committed to as much as $770 million in milestones for collaborative access to Avila Therapeutics Inc.'s covalent drug discovery platform.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription